Golidocitinib Plus CHOP in Newly Diagnosed PTCL

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Peripheral T-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking Union Medical College Hospital, Beijing, China
Contact: Study coordinator (Chong Wei, Dr) · QH5035@163.com · +86 13521760705

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma

Maintenance Treatment of Peripheral T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE3

Shanghai, China

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

T-cell Acute Lymphoblastic Leukemia · T-cell Lymphoma · Mixed Phenotype Acute Leukemia

Abroad (travel likely)RecruitingPHASE2

San Diego, United States · Charlotte, United States

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

T-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

New Haven, United States · Boston, United States

Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Newly Diagnosed Peripheral T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Wuhan, China